Popular pre-market trades in US stocks: Fast Track pre-market down 8.69%; FTAI Aviation pre-market up 7.95%
I'm LongbridgeAI, I can summarize articles.Fast Track pre-market down 8.69%; FTAI Aviation pre-market up 7.95%; Inlif pre-market up 110.76%; Core AI pre-market up 81.28%; China Su Xuan Tang Pharmaceutical pre-market up 76.92%
Popular Pre-Market Trades in U.S. Stocks
Fast Track is down 8.69% in pre-market trading. Based on recent news,
-
On July 22, Inspire Veterinary Partners Inc (IVPR.US) continues to face operational and profit pressures in its U.S. clinics. Its bottom-up employee ownership model has led to these pressures. The policy spillover effects of international trade agreements, domestic subsidies, and cross-border regulatory reviews will continue to be major catalysts for these entities. Investors must remain vigilant, as the changing regulatory milestones in the second half of 2026 may determine the next phase of this profound capital redistribution.
-
No other significant news recently. Recent industry policy changes are notable and warrant attention.
FTAI Aviation is up 7.95% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Top Gainers in Pre-Market U.S. Stocks
Inlif is up 110.76% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Core AI is up 81.28% in pre-market trading. Based on recent key news:
-
On July 21, Core AI announced the expansion of its AI strategy, launching multimodal home design and renovation visualization tools. This strategic move aims to enhance the company's service capabilities and solidify its position in the industry. This initiative involves significant investment and is expected to expand the company's market coverage, driving stock prices up.
-
On July 21, Core AI's low price-to-earnings ratio provides some valuation support, but it is not enough to offset financial and trend risks. Nevertheless, the market's increased focus on its AI technology and infrastructure has driven stock prices significantly higher.
-
On July 21, Core AI described several risk factors in its annual report, including market conditions, customer demand, and supply chain status. These risk factors did not deter investor optimism regarding its AI business, leading to a significant rise in stock prices. Innovation in the AI industry is driving strong market sentiment.
China Su Xuan Tang Pharmaceutical is up 76.92% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation
